To treat relapsed or refractory mantle cell lymphoma in adults who may have experienced at least two strains of systemic therapy, which include a BTK inhibitor Substances for which a petition has been filed but denied on account of lack of evidence of protection. Substances Within this classification are https://milovanu171klk2.creacionblog.com/profile